James H. Quigley - Net Worth and Insider Trading

James H. Quigley Net Worth

The estimated net worth of James H. Quigley is at least $3 Million dollars as of 2024-03-28. James H. Quigley is the Director of Hess Corp and owns about 21,139 shares of Hess Corp (HES) stock worth over $3 Million. James H. Quigley is the Director of Wells Fargo & Co and owns about 2,150 shares of Wells Fargo & Co (WFC) stock worth over $123,862. James H. Quigley is also the Director of Merrimack Pharmaceuticals Inc and owns about 5,650 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $83,451. Details can be seen in James H. Quigley's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James H. Quigley has not made any transactions after 2019-03-06 and currently still holds the listed stock(s).

Transaction Summary of James H. Quigley

To

James H. Quigley Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James H. Quigley owns 3 companies in total, including Hess Corp () , Wells Fargo & Co () , and Merrimack Pharmaceuticals Inc () .

Click here to see the complete history of James H. Quigley’s form 4 insider trades.

Insider Ownership Summary of James H. Quigley

Ticker Comapny Transaction Date Type of Owner
Hess Corp 2019-03-06 director
Wells Fargo & Co 2016-05-03 director
Merrimack Pharmaceuticals Inc 2014-05-19 director

James H. Quigley Latest Holdings Summary

James H. Quigley currently owns a total of 3 stocks. Among these stocks, James H. Quigley owns 21,139 shares of Hess Corp (HES) as of March 6, 2019, with a value of $3 Million and a weighting of 93.88%. James H. Quigley owns 2,150 shares of Wells Fargo & Co (WFC) as of May 3, 2016, with a value of $123,862 and a weighting of 3.65%. James H. Quigley also owns 5,650 shares of Merrimack Pharmaceuticals Inc (MACK) as of May 19, 2014, with a value of $83,451 and a weighting of 2.46%.

Latest Holdings of James H. Quigley

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HES Hess Corp 2019-03-06 21,139 150.55 3,182,476
WFC Wells Fargo & Co 2016-05-03 2,150 57.61 123,862
MACK Merrimack Pharmaceuticals Inc 2014-05-19 5,650 14.77 83,451

Holding Weightings of James H. Quigley


James H. Quigley Form 4 Trading Tracker

According to the SEC Form 4 filings, James H. Quigley has made a total of 0 transactions in Hess Corp (HES) over the past 5 years. The most-recent trade in Hess Corp is the acquisition of 442 shares on March 6, 2019, which cost James H. Quigley around $25,079.

According to the SEC Form 4 filings, James H. Quigley has made a total of 0 transactions in Wells Fargo & Co (WFC) over the past 5 years. The most-recent trade in Wells Fargo & Co is the acquisition of 2,000 shares on May 3, 2016, which cost James H. Quigley around $99,940.

According to the SEC Form 4 filings, James H. Quigley has made a total of 0 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years. The most-recent trade in Merrimack Pharmaceuticals Inc is the acquisition of 500 shares on May 19, 2014, which cost James H. Quigley around $32,900.

Insider Trading History of James H. Quigley

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James H. Quigley Trading Performance

GuruFocus tracks the stock performance after each of James H. Quigley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James H. Quigley is 4.41%. GuruFocus also compares James H. Quigley's trading performance to market benchmark return within the same time period. The performance of stocks bought by James H. Quigley within 3 months outperforms 3 times out of 10 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James H. Quigley's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James H. Quigley

Average Relative Return

13.99%

Average relative return per transaction

Outperforming Transactions

60%

6 out of 10 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 10.73 4.41 9.14 13.99 3.73 1.65
Relative Return to S&P 500(%) 9.39 1.22 4.01 1.73 -7.53 -8.73

James H. Quigley Ownership Network

Ownership Network List of James H. Quigley

No Data

Ownership Network Relation of James H. Quigley


James H. Quigley Owned Company Details

What does Hess Corp do?

Who are the key executives at Hess Corp?

James H. Quigley is the director of Hess Corp. Other key executives at Hess Corp include Senior Vice President Geurt G Schoonman , Senior Vice President Andrew P Slentz , and Senior Vice President Barbara J Lowery-yilmaz .

Hess Corp () Insider Trades Summary

Over the past 18 months, James H. Quigley made no insider transaction in Hess Corp (). Other recent insider transactions involving Hess Corp () include a net sale of 187,776 shares made by Gregory P. Hill , a net sale of 90,296 shares made by Andrew P Slentz , and a net sale of 60,237 shares made by Geurt G Schoonman .

In summary, during the past 3 months, insiders sold 315,139 shares of Hess Corp () in total and bought 0 shares, with a net sale of 315,139 shares. During the past 18 months, 1,008,819 shares of Hess Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,008,819 shares.

Hess Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Hess Corp Insider Transactions

No Available Data

James H. Quigley Mailing Address

Above is the net worth, insider trading, and ownership report for James H. Quigley. You might contact James H. Quigley via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.

Discussions on James H. Quigley

No discussions yet.